PT - JOURNAL ARTICLE AU - Bhad, Roshan AU - Achab, Sophia AU - Rafei, Parnian AU - Kathiresan, Preethy AU - Ardabili, Hossein Mohaddes AU - Butner, Jenna L. AU - Orsolini, Laura AU - Melby, Katrine AU - Farokhnia, Mehdi AU - Narasimha, Venkata Lakshmi AU - Ridley, Kelly AU - Tolomeo, Serenella AU - Kanabar, Mitika AU - Matanje, Beatrice AU - Grandinetti, Paolo AU - , AU - Potenza, Marc N. AU - Ekhtiari, Hamed AU - Baldacchino, Alexander TI - The scope and needs related to training, research, and mentorship among early-career addiction medicine professionals: an online global survey followed by expert group discussions AID - 10.1101/2022.03.24.22272872 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.24.22272872 4099 - http://medrxiv.org/content/early/2022/03/25/2022.03.24.22272872.short 4100 - http://medrxiv.org/content/early/2022/03/25/2022.03.24.22272872.full AB - Addiction medicine is a developing field, with many young professionals opting for a career in this area. However, globally, early-career professionals often face challenges in this field, such as lack of competency-based training due to a shortage of trainers, low availability of institutions with appropriate infrastructure, and limited resources for adequate training, particularly in developing countries. On the other hand, in developed countries, early career professionals may struggle with mentorship, limited job opportunities, and challenges with establishing a suitable research area.The International Society of Addiction Medicine (ISAM) New Professionals Exploration, Training & Education (NExT) committee, a global platform for early-career addiction medicine professionals (ECAMPs), conducted an online survey using a modified Delphi-based approach among ECAMPs across 56 countries to assess and understand the need and scope for standardized training, research opportunities, and mentorship. The survey was conducted in 2 phases. A total of 110 respondents participated in Phase I (online key informant survey), and 28 respondents participated in Phase II (online expert group discussions on the three themes identified in Phase I). Most participants agreed with the lack of standardized training, structured mentorship programmes, research funding, and research opportunities in addiction medicine for ECAMPs. There is a need for standardized training programmes, improving research opportunities, and effective mentorship programmes to promote the next generation of addiction medicine professionals and further development to the entire field. The efforts of ISAM-NExT are well-received and give a template of how this gap can be addressed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific grant from any funding agency, commercial or not-for-profit sectors. MF is supported by NIDA and NIAAA intramural research funding (ZIA-DA000635 and ZIA-AA000218). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The online survey was conducted according to the principles of good scientific practice (15). Ethical approval for the study was sought and granted by the Institutional Ethics Committee (IEC) at the All India Institute of Medical Sciences (AIIMS), New Delhi, India (September 16, 2020, reference number IEC-888/04.09.2020).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableAll relevant data are within the manuscript and its Supporting Information files.